Allergan PLC (AGN)

AGN (NYSE:Drugs) EQUITY
$329.50
pos +2.50
+0.77%
Today's Range: 327.81 - 331.57 | AGN Avg Daily Volume: 2,006,800
Last Update: 07/28/15 - 11:38 AM EDT
Volume: 1,301,416
YTD Performance: 27.03%
Open: $328.11
Previous Close: $326.98
52 Week Range: $201.91 - $334.38
Oustanding Shares: 392,444,638
Market Cap: 120,955,361,878
6-Month Chart
TheStreet Ratings Grade for AGN
Buy Hold Sell
A+ A A- B+ B B- C+ C C- D+ D D- E+ E E- F
TheStreet Ratings is the source for accurate ratings that you can rely upon to make sound, informed financial decisions. Click here to find out about our methodology.
Analysts Ratings
Historical Rec Current 1 Mo. Ago 2 Mo. Ago 3 Mo. Ago
Strong Buy 12 13 14 13
Moderate Buy 3 2 1 1
Hold 1 1 1 1
Moderate Sell 0 0 0 0
Strong Sell 0 0 0 0
Mean Rec. 1.28 1.22 1.16 1.17
Latest Dividend: 0.05
Latest Dividend Yield: 0.08%
Dividend Ex-Date: 02/25/15
Price Earnings Ratio: -31.39
Price Earnings Comparisons:
AGN Sector Avg. S&P 500
-31.39 0.00 28.18
Price Performance History (%Change):
3 Mo 1 Yr 3 Y
14.65% 50.37% 0.00%
GROWTH 12 Mo 3 Yr CAGR
Revenue 50.50 1.85 0.41
Net Income 0.00 -7.29 0.00
EPS 0.00 -4.53 0.00
Earnings for AGN:
EBITDA 3.40B
Revenue 13.06B
Average Earnings Estimates
Qtr (06/15) Qtr (09/15) FY (12/15) FY (12/16)
Average Estimate $4.43 $4.40 $17.93 $21.41
Number of Analysts 6 5 11 11
High Estimate $4.65 $4.55 $18.38 $22.17
Low Estimate $4.31 $4.25 $17.71 $20.61
Prior Year $3.42 $3.19 $13.98 $17.93
Growth Rate (Year over Year) 29.58% 38.06% 28.22% 19.44%
Chart Benchmark Timeframe
Average Frequency Indicator Chart
Scale Symbol Comparison Bollinger Bands
By

Bret Jensen

 | Jul 27, 2015 | 1:00 PM EDT

This week could easily bring additional selling.

By

Jack Mohr

 | Jul 27, 2015 | 12:30 PM EDT

And we are raising our price target on AGN.

By

Antonia Oprita

 | Jul 27, 2015 | 5:30 AM EDT

And four other things you need to know now.

By

Sebastian Silva

 | Jul 26, 2015 | 7:23 PM EDT

Two tech companies in Jim Cramer's charitable trust report as well.

By

Jim Cramer

 | Jul 24, 2015 | 12:32 PM EDT

TheStreet's Jim Cramer answers viewers' Twitter (TWTR) questions from the floor of the New York Stock Exchange.

By

Robert Moreno

 | Jul 23, 2015 | 12:48 PM EDT

Pharmaceutical firm's chart shows a likely move to the upside.

By

Jim Cramer

 | Jul 20, 2015 | 11:27 AM EDT

The fearsome foursome have been reborn.

By

Alan Farley

 | Jul 20, 2015 | 8:00 AM EDT

It's settling into an attractive pattern.

bearishAllergan downgraded at RBC

Jul 17, 2015 | 7:10 AM EDT

AGN was downgraded from Top Pick to Outperform, RBC Capital said. Company lacks near-term catalysts. $361 price target. 

By

Jim Cramer

 | Jul 14, 2015 | 7:11 PM EDT

It was too good to pass up for Celgene.

DuPont had a particularly poor earnings release, outlook and conference call today. As we...

Looks like the margin call on that big mlp fund is done!

Same question put differently; why buy ahead of the Fed tomorrow?

Regarding weak markets; isn't this what you want to see ahead of the Fed tomorrow? Runaw...

REAL MONEY PRO'S BEST IDEAS

News Breaks

Powered by

Columnist Tweets

Except as otherwise indicated, quotes are delayed. Quotes delayed at least 20 minutes for all exchanges. Market Data provided by Interactive Data. Company fundamental data provided by Morningstar. Earnings and ratings provided by Zacks. Mutual fund data provided by Valueline. ETF data provided by Lipper. Powered and implemented by Interactive Data Managed Solutions.

TheStreet Ratings updates stock ratings daily. However, if no rating change occurs, the data on this page does not update. The data does update after 90 days if no rating change occurs within that time period.

IDC calculates the Market Cap for the basic symbol to include common shares only. Year-to-date mutual fund returns are calculated on a monthly basis by Value Line and posted mid-month.